Literature DB >> 3080643

Vascular complications of inflammatory bowel disease.

R W Talbot, J Heppell, R R Dozois, R W Beart.   

Abstract

During an 11-year period from January 1970 to December 1980, 7,199 patients at our institution had chronic ulcerative colitis or Crohn's disease. Thromboembolic complications developed in 92 (1.3%) of these patients. An additional 4 patients had cutaneous vasculitis, and 17 had an arteritis-associated diagnosis. Of the thromboembolic complications, 61 were deep vein thromboses or pulmonary emboli. The mortality among patients with thromboembolic complications was high (25%). Sixty percent of the patients had a thrombocytosis unaffected by sulfasalazine or corticosteroid therapy. In 73% of the patients, the erythrocyte sedimentation rate was increased, and when measured, fibrinogen and factor VIII were commonly elevated. Peripheral arterial thrombosis, coronary thrombosis, and mesenteric and portal vein thrombosis were predominantly postsurgical complications, but 77% of peripheral venous thromboses occurred spontaneously. The role of anticoagulation and surgical intervention in the management of hypercoagulation in patients with inflammatory bowel disease is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3080643     DOI: 10.1016/s0025-6196(12)65200-8

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  137 in total

1.  Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications.

Authors:  N Mahmud; A Molloy; J McPartlin; R Corbally; A S Whitehead; J M Scott; D G Weir
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Hyperhomocysteinemia in Greek patients with inflammatory bowel disease.

Authors:  I E Koutroubakis; E Dilaveraki; I G Vlachonikolis; E Vardas; G Vrentzos; E Ganotakis; I A Mouzas; A Gravanis; D Emmanouel; E A Kouroumalis
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

3.  Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial.

Authors:  R S McLeod; W H Geerts; K W Sniderman; C Greenwood; R C Gregoire; B M Taylor; R E Silverman; K G Atkinson; M Burnstein; J C Marshall; C J Burul; D R Anderson; T Ross; S R Wilson; P Barton
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 4.  Mesenteric arterial thrombosis as a complication of Crohn's disease.

Authors:  P Sanghavi; A Paramesh; A Dwivedi; T Markova; T Phan
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

5.  Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis.

Authors:  R K Linskens; A A van Bodegraven; M Schoorl; H A Tuynman; P Bartels
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

6.  Ulcerative colitis complicated by dural sina venous thrombosis.

Authors:  Antonio Macrì; Paolino La Spina; Maria Luisa Terranova; Marcello Longo; Giuseppe Gallitto; Giuseppe Scuderi; Rossella Musolino; Ciro Famulari
Journal:  Int J Colorectal Dis       Date:  2002-01       Impact factor: 2.571

7.  Veno-occlusive disease (VOD) in Crohn's disease (CD) treated with azathioprine.

Authors:  M Holtmann; O Schreiner; H Köhler; U Denzer; M Neurath; P R Galle; T Höhler
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

8.  Portal vein thrombosis in a complicated case of Crohn's disease.

Authors:  A Crowe; N Taffinder; G T Layer; A Irvine; R J Nicholls
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

9.  [Central vein thrombosis in a young patient. 31 year old patient with unilateral acute impaired vision and a history of ulcerative colitis].

Authors:  J von Eicken; W Inhoffen; U Schneider
Journal:  Ophthalmologe       Date:  2003-06-19       Impact factor: 1.059

10.  Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia.

Authors:  Bas Oldenburg; Bas A C Van Tuyl; René van der Griend; Rob Fijnheer; Gerard P van Berge Henegouwen
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.